Compugen hosts virtual KOL event on COM701 in ovarian cancer

PUBT · 1d ago
Compugen hosts virtual KOL event on COM701 in ovarian cancer
  • Compugen will host a virtual KOL event on October 5, 2026 at 8:00 a.m. ET focused on COM701 in ovarian cancer.
  • Harvard Medical School’s Oladapo Yeku will join management to discuss the evolving ovarian cancer treatment landscape.
  • The session will also include an update on expanded capabilities of the Unigen AI/ML target discovery platform.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compugen Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609220700PR_NEWS_USPR_____IO53662) on September 22, 2026, and is solely responsible for the information contained therein.